TANG CAPITAL MANAGEMENT LLC - 30 Sep 2025 SCHEDULE 13G/A Report for ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share (ALXO)

Filing Manager
TANG CAPITAL MANAGEMENT LLC
Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Security
ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share
Symbol
ALXO
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:17:03 UTC
Date of event
30 Sep 2025
Previous filing
15 May 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"TANG CAPITAL MANAGEMENT LLC disclosed 0% ownership in ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share (ALXO) on 30 Sep 2025."

Quick Takeaways

  • TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share (ALXO).
  • Disclosed ownership: 0%.
  • Date of event: 30 Sep 2025.

What Changed

  • Previous schedule filing date: 15 May 2025.
  • Current filing was accepted on 14 Nov 2025, 16:17.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 0% 0 0 0 Kevin Tang Manager
KEVIN TANG 0% 0 0 0 Kevin Tang Self
TANG CAPITAL PARTNERS, LP 0% 0 0 0 Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS INTERNATIONAL, LP 0% 0 0 0 Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC 0% 0 0 0 Kevin Tang Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC 0% 0 0 0 Kevin Tang Chief Executive Officer

Sponsored